GlassScriptPhysician profile
Barbara Geater
NPI 1679509707
$2,343.39
in general payments reported to CMS, 2019-2025
22 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $178 · 2021: $245 · 2022: $433 · 2023: $293 · 2024: $318 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $410.74 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $319.16 | 2019-2024 | Rybelsus |
| Mannkind Corporation | $233.29 | 2019-2024 | Afrezza |
| Janssen Pharmaceuticals, INC | $229.08 | 2021-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $182.68 | 2022-2025 | |
| Organogenesis INC. | $134.29 | 2025 | Puraply Wound Matrix |
| Neurocrine Biosciences, INC. | $113.06 | 2023-2024 | Ingrezza, Ongentys |
| Pfizer INC. | $108.67 | 2019-2025 | |
| Exact Sciences Corporation | $92.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $89.17 | 2019-2020 | |
| Glaxosmithkline, LLC. | $82.20 | 2019-2025 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $72.34 | 2019 | |
| Dexcom, INC. | $62.51 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $44.40 | 2021-2024 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $38.53 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $30.96 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $20.15 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.39 | 2020 | |
| Sunovion Pharmaceuticals INC. | $19.06 | 2019 | |
| Medtronic Minimed, INC. | $17.55 | 2019 | |
| Smith+Nephew, INC. | $15.18 | 2025 | Collagenase Santyl |
| Advanced Oxygen Therapy INC. | $8.08 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Geater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.